Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

 

    Warrants     Weighted
Average
Exercise Price
 
             
Outstanding – December 31, 2019     6,849,635     $ 0.71  
Exercisable – December 31, 2019     6,849,635     $ 0.71  
Granted     714,284     $ -  
Exercised     -     $ -  
Forfeited/Cancelled     -     $ -  
Outstanding – June 30, 2020     7,563,919     $ 0.69  
Exercisable – June 30, 2020     7,563,919     $ 0.69  
Schedule of Warrants Outstanding and Exercisable
Warrants Outstanding     Warrants Exercisable  
Exercise Price     Number Outstanding     Weighted Average Remaining Contractual Life (in years)     Weighted Average Exercise Price     Number Exercisable     Weighted Average Exercise Price  
                                             
$ 0.40 – 3.00       7,563,919       1.61 years     $ 0.69       7,563,919     $ 0. 69  
Schedule of Assumption Used Value of Options

For the six months ended June 30, 2019, when computing fair value of share-based payments, the Company has considered the following variables:

 

    June 30, 2019  
Risk-free interest rate     2.50 %
Expected life of grants     3 years  
Expected volatility of underlying stock     168.71 %
Dividends     0 %